Related Products

A Site-Specific B7-H3 Targeting Antibody-Drug Conjugate for Cancer Therapy

UB-941: A Selective & Orally Active Raf Kinase Inhibitor as a Precision Medicine / Melanoma

PD-L1/TIM-3/CSF-1R antibody in preclinical studies for Cancer Immunotherapy

Development of Novel Selective FPR1 Antagonist Against Neutrophil Related Inflammatory Disease